Corporate Profile
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com or follow us on LinkedIn
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Events
SEC Filings
| Filing date | Description | Form |
|---|---|---|
Registration of securities of foreign private issuers pursuant to section 12(b) or (g) |
20-F | |
Registration of securities of foreign private issuers pursuant to section 12(b) or (g) |
20-F | |
Form of prospectus disclosing information facts events covered in both forms 424B1 424B3 |
424B4 |